Article info
Pancreas
Original article
Nr5a2 maintains acinar cell differentiation and constrains oncogenic Kras-mediated pancreatic neoplastic initiation
- Correspondence to Dr Matthias Hebrok, Department of Medicine, University of California-San Francisco, Diabetes Center, 513 Parnassus Avenue, HSW 1116, Box 0540, San Francisco, CA 94143-0573, USA; mhebrok{at}diabetes.ucsf.edu
Citation
Nr5a2 maintains acinar cell differentiation and constrains oncogenic Kras-mediated pancreatic neoplastic initiation
Publication history
- Received December 13, 2012
- Revised March 17, 2013
- Accepted April 4, 2013
- First published May 3, 2013.
Online issue publication
April 18, 2016
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions